GlassScriptPhysician profile
Anthony J Matteo
NPI 1063636694
$1,471.73
in general payments reported to CMS, 2019-2025
17 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $199 · 2021: $280 · 2022: $444 · 2023: $214 · 2024: $51.81 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $387.24 | 2019-2023 | |
| Therapeuticsmd, INC. | $287.08 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $174.05 | 2021-2023 | |
| Coopersurgical, INC. | $106.69 | 2021-2025 | Paragard T 380a, Paragard T 380a |
| Avion Pharmaceuticals | $97.60 | 2019-2022 | |
| Millicent US INC | $71.66 | 2021-2025 | Intrarosa, Femring, Femlyv |
| Myovant Sciences INC. | $70.27 | 2021-2022 | |
| Boston Scientific Corporation | $52.65 | 2019-2020 | |
| Hologic Sales and Service, LLC | $39.44 | 2025 | Thinprep 2000 Processor, Aptima |
| Astellas Pharma US INC | $38.78 | 2023-2024 | Veozah |
| Urovant Sciences INC | $34.09 | 2022 | |
| Merck Sharp & Dohme LLC | $22.49 | 2020 | |
| Amgen INC. | $20.80 | 2021 | |
| Electromed, INC. | $19.43 | 2025 | Smartvest |
| Sumitomo Pharma America, INC. | $17.94 | 2023 | Myfembree |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dysis Medical, INC. | $16.91 | 2022 | |
| Allergan, INC. | $14.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Matteo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.